Starboard Value Issues Letter to Pfizer’s (PFE) Board of Directors
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Starboard Value Issues Letter to Pfizer’s Board of Directors
October 10, 2024 8:45 AM EDTNEW YORK--(BUSINESS WIRE)-- Starboard Value LP (together with its affiliates, Starboard or we), a significant shareholder of Pfizer Inc. (NYSE: PFE) (Pfizer or the Company), today issued the below letter to Companys Board of Directors.
***
October 10, 2024
Pfizer Inc.
66 Hudson Boulevard East
New York, New York
10001
Attn: Board of Directors
CC: Doug Lankler, General Counsel
Dear Members of the Board,
As you know, Starboard Value LP (together with its affiliates, Starboard or we) is a large investor in Pfizer Inc. (Pfizer or the... More
